Pfizer/BioNTech COVID-19 vaccine shows 90.7% efficacy in trial in children
Posted on AllSides October 22nd, 2021
From The Center
The Pfizer (PFE.N)/BioNTech COVID-19 vaccine showed 90.7% efficacy against the coronavirus in a clinical trial of children 5 to 11 years old, the U.S. drugmaker said on Friday.
